Amdocs Limited Reports Record Quarterly Revenue of $864M, Up 4.6% YoY - KPTV - FOX 12

Amdocs Limited Reports Record Quarterly Revenue of $864M, Up 4.6% YoY

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Amdocs Limited

Reiterates FY14 Non-GAAP Diluted EPS Growth Outlook of 6-9% YoY

Closed Acquisition of Celcite

ST. LOUIS, Jan. 29, 2014 /PRNewswire/ --

Key highlights:

  • Closed the previously announced acquisition of Celcite on January 1, 2014, for $141 million in cash
  • First fiscal quarter revenue of $864 million, within the $845-$875 million guidance range. Foreign currency movements positively affected revenue by approximately $2 million relative to the fourth quarter of fiscal 2013
  • First fiscal quarter non-GAAP operating income of $145 million; non-GAAP operating margin of 16.8%; GAAP operating income of $121 million
  • First fiscal quarter diluted non-GAAP EPS of $0.76, within the $0.72-$0.78 guidance range, excluding amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expense, net of related tax effects
  • Diluted GAAP EPS of $0.63 for the first fiscal quarter, within the $0.58-$0.66 guidance range
  • Free cash flow of $160 million for the first fiscal quarter
  • Twelve-month backlog of $2.89 billion at the end of the first fiscal quarter, up $20 million from the end of the fourth quarter of fiscal 2013
  • Repurchased $84 million of ordinary shares during the first fiscal quarter
  • The board of directors approved a $0.155 per share quarterly cash dividend to be paid on April 17, 2014, subject to shareholder approval  
  • Second quarter fiscal 2014 guidance: Expected revenue of approximately $880-$910 million which includes full quarter contributions from recently closed acquisitions.  Expected diluted non-GAAP EPS of approximately $0.75-$0.81, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects.  Expected diluted GAAP EPS of approximately $0.61-$0.69

Amdocs Limited (NASDAQ: DOX) today reported that for its fiscal quarter ended December 31, 2013, revenue was $864.0 million, up 2.2% sequentially from the fourth fiscal quarter of 2013 and up 4.6% as compared to last year's first fiscal quarter. Net income on a non-GAAP basis was $122.6 million, or $0.76 per diluted share, compared to non-GAAP net income of $119.4 million, or $0.73 per diluted share, in the first quarter of fiscal 2013. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expenses of $21.1 million, net of related tax effects, in the first quarter of fiscal 2014 and excludes such amortization and other acquisition related costs and equity-based compensation expenses of $20.4 million, net of related tax effects, in the first quarter of fiscal 2013. The Company's GAAP net income for the first quarter of fiscal 2014 was $101.4 million, or $0.63 per diluted share, compared to GAAP net income of $99.0 million, or $0.61 per diluted share, in the prior fiscal year's first quarter. 

"We made a solid start to fiscal 2014, with total revenue, profitability and earnings per share consistent with our expectations.  North America was strong as we supported our key customers, including AT&T, in their strategic initiatives as competition amongst carriers becomes increasingly fierce. In Europe, recent wins contributed to year-over-year growth in the region for the first time in five quarters. Finally, in the emerging markets, our first quarter results reflect normal fluctuations of delivery milestones on transformation projects; however, the long-term secular drivers remain favorable and we are strategically well placed to execute against the rich pipeline of opportunity we see ahead of us," said Eli Gelman, chief executive officer of Amdocs Management Limited.

Gelman continued, "During the first fiscal quarter, we extended our relationships with customers in Europe, including Telekom Austria for the implementation of a billing modernization project based on Amdocs Turbo Charging. Additionally, our customers continued to recognize the benefits of our managed services model to deliver innovative offerings to their customers in a more cost effective way. Along these lines, we strengthened our partnership with one of Asia Pacific's leading Pay TV providers by signing a five-year, long-term service engagement. In Europe, we were selected by UK Mobile operator, EE, to deploy our MVNE solution under a managed service contract. We also on-boarded another affiliate of Vodafone Group to the global managed services agreement we signed in fiscal 2013."

Gelman said, "We are also encouraged by our strategic initiatives in radio network optimization. We completed the acquisition of Celcite on January 1, 2014 and the post-merger integration of Actix is underway. Both of these acquired companies secured new customer wins during the first quarter, and we anticipate additional success over the longer term as we realize the benefits and synergies of our integrated network software business under Amdocs."

Gelman concluded, "We are closely monitoring the many uncertainties in the global business environment, including those resulting from announced and potential consolidation activity amongst North American operators. We currently expect to deliver full year total revenue growth of 5% to 8% in fiscal 2014. This is slightly ahead of our previous outlook as we factor in the timing of M&A deal closings and the performance of recently acquired assets. These include Actix, Celcite and a small IT services provider in Latin America that we acquired late in the first fiscal quarter. Our free cash flow generation remains robust and we remain confident in our ability to return cash to shareholders. Taking all these factors into consideration, we continue to expect non-GAAP earnings per share growth of 6-9% in fiscal 2014."

Financial Discussion of First Fiscal Quarter Results

Free cash flow was $160 million for the quarter, comprised of cash flow from operations of $187 million less $27 million in net capital expenditures and other.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.89 billion at the end of the first quarter of fiscal 2014. 

Financial Outlook

Amdocs expects that revenue for the second quarter of fiscal 2014 will be approximately $880-$910 million. Diluted earnings per share on a non-GAAP basis for the second fiscal quarter are expected to be $0.75-$0.81, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the second fiscal quarter will be $0.61-$0.69

Quarterly Cash Dividend Program

On January 29, 2014, the Board approved the Company's next quarterly cash dividend payment of $0.155 and set March 31, 2014, as the record date for determining the shareholders entitled to receive the dividend, which is payable on April 17, 2014. The increased dividend is subject to shareholder approval at the Company's Annual General Meeting on January 30, 2014.

Conference Call Details

Amdocs will host a conference call on January 29, 2014 at 5:00 p.m. Eastern Time to discuss the Company's first fiscal quarter results. The call will be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:

  • amortization of purchased intangible assets and other acquisition related costs;
  • equity-based compensation expense; and
  • tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets and other acquisition related costs, equity-based compensation expense and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, interest and other expense, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

About Amdocs

For 30 years, Amdocs has ensured service providers' success and embraced their biggest challenges. To win in the connected world, service providers rely on Amdocs to simplify the customer experience, harness the data explosion, stay ahead with new services and improve operational efficiency. The global company uniquely combines a market-leading BSS, OSS and network control and optimization product portfolio with value-driven professional services and managed services operations.  With revenue of $3.3 billion in fiscal 2013, Amdocs and its 21,000 employees serve customers in more than 70 countries.

Amdocs: Embrace Challenge, Experience Success.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2013 filed on December 9, 2013.

AMDOCS LIMITED

Consolidated Statements of Income

(in thousands, except per share data)






Three months ended



December 31,



2013


2012




Revenue:





License


$             27,209


$             18,916

Service


836,836


807,443



864,045


826,359

Operating expenses:





Cost of license


770


636

Cost of service


556,633


535,013

Research and development


62,325


59,360

Selling, general and administrative


111,959


107,460

Amortization of purchased intangible assets and other

11,668


11,233



743,355


713,702

Operating income


120,690


112,657






Interest and other expense, net


1,404


108

Income before income taxes


119,286


112,549






Income taxes


17,851


13,534

Net income


$           101,435


$             99,015

Basic earnings per share


$                 0.64


$                 0.61

Diluted earnings per share


$                 0.63


$                 0.61

Basic weighted average number of shares outstanding

159,659


162,176

Diluted weighted average number of shares outstanding

161,845


163,587

Cash dividends declared per share


$                 0.13


$                 0.13

 

AMDOCS LIMITED

Selected Financial Metrics

(in thousands, except per share data)






Three months ended



December 31,



2013


2012






Revenue


$     864,045


$     826,359






Non-GAAP operating income


145,323


137,215






Non-GAAP net income


122,564


119,424






Non-GAAP diluted earnings per share


$           0.76


$          0.73






Diluted weighted average number of shares outstanding

161,845


163,587



AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)






Three months ended

December 31, 2013




Reconciliation items




GAAP

Amortization of
purchased
intangible assets
and other

Equity based
compensation
expense

Tax effect

Non-GAAP








Operating expenses:







Cost of license


$         770

$                 -

$               -

$             -

$           770

Cost of service


556,633

-

(4,554)

-

552,079

Research and development


62,325

-

(933)

-

61,392

Selling, general and administrative


111,959

-

(7,478)

-

104,481

Amortization of purchased intangible assets and other

11,668

(11,668)

-

-

-

Total operating expenses


743,355

(11,668)

(12,965)

-

718,722








Operating income


120,690

11,668

12,965

-

145,323








Income taxes


17,851

-

-

3,504

21,355








Net income


$  101,435

$      11,668

$       12,965

$  (3,504)

$  122,564

















Three months ended

December 31, 2012




Reconciliation items




GAAP

Amortization of
purchased
intangible assets
and other

Equity based
compensation
expense

Tax effect

 

Non-GAAP








Operating expenses:







Cost of license


$         636

$                 -

$               -

$             -

$            636

Cost of service


535,013

-

(5,033)

-

529,980

Research and development


59,360

-

(1,025)

-

58,335

Selling, general and administrative


107,460

-

(7,267)

-

100,193

Amortization of purchased intangible assets and other

11,233

(11,233)

-

-

-

Total operating expenses


713,702

(11,233)

(13,325)

-

689,144








Operating income


112,657

11,233

13,325

-

137,215








Income taxes


13,534

-

-

4,149

17,683








Net income


$    99,015

$      11,233

$       13,325

$  (4,149)

$  119,424








 

AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(in thousands)




As of



December 31, 
2013


September 30, 
2013






ASSETS










Current assets





Cash, cash equivalents and short-term interest-bearing investments


$     1,211,558


$    1,326,380

Accounts receivable, net, including unbilled of $117,037 and $110,626, respectively

680,947


678,219

Deferred income taxes and taxes receivable


161,810


125,880

Prepaid expenses and other current assets


182,395


151,595

    Total current assets


2,236,710


2,282,074






Equipment and leasehold improvements, net


266,404


275,544

Goodwill and other intangible assets, net


1,972,777


1,975,060

Other noncurrent assets


382,065


393,135

Total assets


$    4,857,956


$    4,925,813






LIABILITIES AND SHAREHOLDERS' EQUITY










Current Liabilities





Accounts payable, accruals and other


$      716,709


$      683,768

Short-term financing arrangements


-


200,000

Deferred revenue


173,284


151,112

Deferred income taxes and taxes payable


50,848


39,376

    Total current liabilities


940,841


1,074,256

Other noncurrent liabilities


584,103


576,774

Shareholders' equity


3,333,012


3,274,783

Total liabilities and shareholders' equity


$    4,857,956


$    4,925,813

 

AMDOCS LIMITED

Consolidated Statements of Cash Flows

(in thousands)






Three months ended December 31,



2013


2012






Cash Flow from Operating Activities:





Net income


$        101,435


$          99,015

Reconciliation of net income to net cash provided by operating activities:




    Depreciation and amortization


35,729


39,288

    Equity-based compensation expense


12,965


13,325

    Deferred income taxes


5,397


3,782

Excess tax benefit from equity-based compensation


(92)


(56)

    Loss from short-term interest-bearing investments


308


481

Net changes in operating assets and liabilities, net of amounts acquired:




    Accounts receivable


(3,660)


9,306

    Prepaid expenses and other current assets


(7,596)


(21,054)

    Other noncurrent assets


(14,453)


(3,879)

    Accounts payable, accrued expenses and accrued personnel


34,514


9,868

    Deferred revenue


20,460


(7,155)

    Income taxes payable


(4,565)


(8,752)

    Other noncurrent liabilities


6,096


11,294

Net cash provided by operating activities


186,538


145,463






Cash Flow from Investing Activities:





Payments for purchase of equipment and leasehold improvements, net

(26,743)


(29,903)

Proceeds from sale of short-term interest-bearing investments


83,763


76,296

Purchase of short-term interest-bearing investments


(92,878)


(158,059)

Net cash paid for acquisitions


(12,603)


-

Other


7,309


(1,530)

Net cash used in investing activities


(41,152)


(113,196)






Cash Flow from Financing Activities:





Payments under financing arrangements


(200,000)


(200,000)

Repurchase of shares


(84,019)


(103,707)

Proceeds from employee stock options exercised


36,014


54,358

Payments of dividends


(20,812)


(21,120)

Payments under capital lease and other


(178)


(181)

Net cash used in financing activities


(268,995)


(270,650)






Net decrease in cash and cash equivalents


(123,609)


(238,383)

Cash and cash equivalents at beginning of period


1,014,192


879,158

Cash and cash equivalents at end of period


$        890,583


$        640,775



AMDOCS LIMITED

Supplementary Information

(in millions)






Three months ended



December 31,
2013


September 30,
2013


June 30,
2013


March 31,
2013


December 31,
2012

North America


$      628.0


$      608.9


$      619.2


$      601.3


$      593.6

Europe


117.0


101.9


98.0


99.3


99.2

Rest of the World


119.0


134.4


124.1


132.3


133.6

Total Revenue


$      864.0


$      845.2


$      841.3


$      832.9


$      826.4

















As of



December 31,
2013


September 30,
2013


June 30,
2013


March 31,
2013


December 31,
2012

Emerging Markets Revenue

$      100.7


$      113.8


$      101.3


$      98.1


$      98.2

















As of



December 31,
2013


September 30,
2013


June 30,
2013


March 31,
2013


December 31,
2012

Managed Services Revenue

$      429.3


$      414.0


$      417.1


$      439.8


$      429.8

















Three months ended



December 31,
2013


September 30,
2013


June 30,
2013


March 31,
2013


December 31,
2012

Customer Experience Systems

$      829.6


$      809.3


$      803.2


$      789.3


$      783.8

Directory


34.4


35.9


38.1


43.6


42.6

Total Revenue


$      864.0


$      845.2


$      841.3


$      832.9


$      826.4

























As of



December 31,
2013


September 30,
2013


June 30,
2013


March 31,
2013


December 31,
2012

12-Month Backlog


$      2,890


$      2,870


$      2,830


$      2,810


$      2,800

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
FOX 12
Powered by WorldNow CNN
All content © 2014, KPTV-KPDX Broadcasting Corporation, Portland, OR and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.